Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials
- PMID: 23651522
- DOI: 10.1017/S0007114513000548
Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials
Abstract
The role of very-low-carbohydrate ketogenic diets (VLCKD) in the long-term management of obesity is not well established. The present meta-analysis aimed to investigate whether individuals assigned to a VLCKD (i.e. a diet with no more than 50 g carbohydrates/d) achieve better long-term body weight and cardiovascular risk factor management when compared with individuals assigned to a conventional low-fat diet (LFD; i.e. a restricted-energy diet with less than 30% of energy from fat). Through August 2012, MEDLINE, CENTRAL, ScienceDirect,Scopus, LILACS, SciELO, ClinicalTrials.gov and grey literature databases were searched, using no date or language restrictions, for randomised controlled trials that assigned adults to a VLCKD or a LFD, with 12 months or more of follow-up. The primary outcome was bodyweight. The secondary outcomes were TAG, HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C), systolic and diastolic blood pressure,glucose, insulin, HbA1c and C-reactive protein levels. A total of thirteen studies met the inclusion/exclusion criteria. In the overall analysis,five outcomes revealed significant results. Individuals assigned to a VLCKD showed decreased body weight (weighted mean difference -0·91 (95% CI -1·65, -0·17) kg, 1415 patients), TAG (weighted mean difference -0·18 (95% CI -0·27, -0·08) mmol/l, 1258 patients)and diastolic blood pressure (weighted mean difference -1·43 (95% CI -2·49, -0·37) mmHg, 1298 patients) while increased HDL-C(weighted mean difference 0·09 (95% CI 0·06, 0·12) mmol/l, 1257 patients) and LDL-C (weighted mean difference 0·12 (95% CI 0·04,0·2) mmol/l, 1255 patients). Individuals assigned to a VLCKD achieve a greater weight loss than those assigned to a LFD in the longterm; hence, a VLCKD may be an alternative tool against obesity.
Comment in
-
Low-carbohydrate diets impair flow-mediated dilatation: evidence from a systematic review and meta-analysis.Br J Nutr. 2013 Sep 14;110(5):969-70. doi: 10.1017/S000711451300216X. Epub 2013 Jul 5. Br J Nutr. 2013. PMID: 23829973 No abstract available.
Similar articles
-
Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials.BMJ. 2020 Apr 1;369:m696. doi: 10.1136/bmj.m696. BMJ. 2020. PMID: 32238384 Free PMC article.
-
Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials.Br J Nutr. 2016 Feb 14;115(3):466-79. doi: 10.1017/S0007114515004699. Br J Nutr. 2016. PMID: 26768850
-
Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis.J Acad Nutr Diet. 2013 Dec;113(12):1640-61. doi: 10.1016/j.jand.2013.07.010. Epub 2013 Oct 17. J Acad Nutr Diet. 2013. PMID: 24139973 Review.
-
Low-carbohydrate diets impair flow-mediated dilatation: evidence from a systematic review and meta-analysis.Br J Nutr. 2013 Sep 14;110(5):969-70. doi: 10.1017/S000711451300216X. Epub 2013 Jul 5. Br J Nutr. 2013. PMID: 23829973 No abstract available.
-
Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials.Arch Intern Med. 2006 Feb 13;166(3):285-93. doi: 10.1001/archinte.166.3.285. Arch Intern Med. 2006. PMID: 16476868 Review.
Cited by
-
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408. Nutrients. 2024. PMID: 38794646 Free PMC article.
-
The Significant Impact of High-Fat, Low-Carbohydrate Ketogenic Diet on Serum Lipid Profile and Atherosclerotic Cardiovascular Disease Risk in Overweight and Obese Adults.Cureus. 2024 Apr 9;16(4):e57920. doi: 10.7759/cureus.57920. eCollection 2024 Apr. Cureus. 2024. PMID: 38725767 Free PMC article.
-
Effect of Ketogenic Diet on Obesity and Other Metabolic Disorders: Narrative Review.Diabetes Metab Syndr Obes. 2024 Mar 21;17:1391-1401. doi: 10.2147/DMSO.S447659. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38529169 Free PMC article. Review.
-
CMS121: a novel approach to mitigate aging-related obesity and metabolic dysfunction.Aging (Albany NY). 2024 Mar 20;16(6):4980-4999. doi: 10.18632/aging.205673. Epub 2024 Mar 20. Aging (Albany NY). 2024. PMID: 38517358 Free PMC article.
-
The Ketone Bridge Between the Heart and the Bladder: How Fast Should We Go?Int Neurourol J. 2024 Feb;28(Suppl 1):2-11. doi: 10.5213/inj.2346250.125. Epub 2024 Feb 29. Int Neurourol J. 2024. PMID: 38461852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous